Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. The Inside Battelle blog from Anthony Duong explains. #GeneTherapies #Nanomedicine https://okt.to/sTXkwR
Battelle Health’s Post
More Relevant Posts
-
Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. The Inside Battelle blog from Anthony Duong explains. #GeneTherapies #Nanomedicine https://okt.to/3jc6OM
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Our new blog from Anthony Duong Ph.D. dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/KimXzS
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Read more from Anthony Duong Ph.D. as he dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/AeqsBC
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Read more from Anthony Duong Ph.D. as he dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/Rk1vLu
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Our new blog from Anthony Duong Ph.D. dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/3tgBdI
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
A new era of personalized medicine is upon us. Gene therapies and nanomedicines are at the forefront of this revolution and are changing how we approach disease treatment and prevention. Read this Inside Battelle blog to get smarter on the subject: https://okt.to/aURTtQ
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
A new era of personalized medicine is upon us. Gene therapies and nanomedicines are at the forefront of this revolution and are changing how we approach disease treatment and prevention. Read this Inside Battelle blog to get smarter on the subject: https://okt.to/kyDB7U
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
It's a new world and gene therapies and nanomedicines are shaping the future of personalized medicine. Battelle scientists have created the HIT SCAN system, a delivery vehicle platform containing nanocarriers that can serve as components of new genetic drug products. But how do we navigate the regulatory pathways to realize their full potential? In this new Inside Battelle blog, Anthony Duong explores this topic in depth. #GeneticNanomedicines #PrecisionMedicine https://okt.to/IF4BZ5
New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway
inside.battelle.org
To view or add a comment, sign in
-
Demand for #advancedtherapies, such as cell and gene therapies, is growing and won’t stop anytime soon. To get these innovative treatments to patients as quickly as possible, it is critical for #CDMOs to evolve to meet the needs of #pharma and #biotech customers as they work to move medicines from #clinicaltrials to commercialization. I recently had the opportunity to sit down with [@Clinical Trials Arena] to discuss how our newly opened cold and ultra-cold facility in the #Netherlands will enable our partners in the EU to advance medicines. Read more from our conversation here: https://lnkd.in/e9j3Rs2e
Thermo Fisher Scientific: meeting the rising demand for ultra-cold storage
clinicaltrialsarena.com
To view or add a comment, sign in
-
Associate Director, Regulatory Affairs at Boyds | Investigational Product Lifecycle Development | Cell and Gene Therapy | Multidisciplinary Strategy | Team and Project Leadership
Really enjoyed penning this commentary article for TOPRA on cell and gene therapy development for rare diseases in the US!
🧬An article written by Dr Eric Hardter, discussing cell and gene therapy rare disease drug development in the US, has been published on the commentary section of the TOPRA - The Organisation for Professionals in Regulatory Affairs website. Read more: https://lnkd.in/eH37sXtU
Cell and gene therapy rare disease drug development in the US – general principles, challenges and a landscape of mutual regulatory concession
regulatoryrapporteur.org
To view or add a comment, sign in
220 followers